Philip Robinson

Lung Disease at Diagnosis in Infants with Cystic Fibrosis Detected by Newborn Screening

Peter D. Sly, Siobhain Brennan, Catherine Gangell et al. · American Journal of Respiratory and Critical Care Medicine · 2009 · 544 citations

Improved Detection of Focal Liver Lesions at MR Imaging: Multicenter Comparison of Gadoxetic Acid–enhanced MR Images with Intraoperative Findings

Alexander Huppertz, Thomas Balzer, A. Blakeborough et al. · Radiology · 2004 · 395 citations

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

Joanne Quan, Harm A.W.M. Tiddens, Judy P. Sy et al. · The Journal of Pediatrics · 2001 · 299 citations

Two-year Randomized, Pulmonary Care, Advanced Lung Disease +5

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 291 citations

Pulmonary Fibrosis, Medicine, Placebo-controlled Phase 3

Infection, Inflammation, and Lung Function Decline in Infants with Cystic Fibrosis

Naveen Pillarisetti, Elizabeth Williamson, Barry Linnane et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 282 citations